CH
ORIAW

CVI Holdings’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

CVI Holdings’s Portfolio ORIAW Stock Details ORIAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,996
Closed -$1K – 726
2022
Q3 		$1K Hold
10,996
– – ﹤0.01% 852
2022
Q2 		$2K Sell
10,996
-2,194
-17% -$710 ﹤0.01% 914
2022
Q1 		$5K Sell
13,190
-6,810
-34% -$3.51K ﹤0.01% 912
2021
Q4 		$19K Hold
20,000
– – ﹤0.01% 885
2021
Q3 		$17K Buy
+20,000
New +$26K ﹤0.01% 859

Other funds holding ORIAW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
GAM
Gritstone Asset Management Bethesda, Maryland $104M AUM 6.03% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

CVI Holdings's ORIAW Position: Q4 2022 in Review

CVI Holdings sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q4 2022, closing a stake of 10,996 shares — an estimated $1K sold.

CVI Holdings first reported a position in ORIAW in Q3 2021 and held it in 5 quarters. The position peaked at $19K in Q4 2021. 29 funds tracked by Wall St. Rank hold ORIAW as of Q4 2022.

  • CVI Holdings reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q4 2022 after selling out during the quarter.
  • CVI Holdings sold 10,996 Orion Biotech Opportunities Corp. Warrant shares in Q4 2022, an estimated $1K.
  • CVI Holdings first reported a position in Orion Biotech Opportunities Corp. Warrant in Q3 2021 and held it in 5 quarters.
  • CVI Holdings's Orion Biotech Opportunities Corp. Warrant position peaked at $19K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q4 2022.

Based on CVI Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.